amiodarone has been researched along with Marfan Syndrome in 3 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a 20-year-old patient with Marfan's syndrome and Wolff-Parkinson-White syndrome, effective amiodarone treatment had to be stopped due to serious hyperthyroidism." | 7.67 | Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome. ( Hazenberg, HJ; Tietge, FC, 1985) |
| "In a 20-year-old patient with Marfan's syndrome and Wolff-Parkinson-White syndrome, effective amiodarone treatment had to be stopped due to serious hyperthyroidism." | 3.67 | Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome. ( Hazenberg, HJ; Tietge, FC, 1985) |
| "They include progressive and acute mitral insufficiency, infective endocarditis, arrhythmias, motor or sensitive neurological complications, and sudden death." | 2.36 | [Idiopathic mitral valve prolapse]. ( Barbato, G; Martelli, M; Saponaro, A, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martelli, M | 1 |
| Barbato, G | 1 |
| Saponaro, A | 1 |
| Pérez Parras, MA | 1 |
| Marín Patón , M | 1 |
| Negrillo Cantero, AM | 1 |
| Caro Cruz , E | 1 |
| González Rivera , F | 1 |
| Moreno Carazo , A | 1 |
| Hazenberg, HJ | 1 |
| Tietge, FC | 1 |
1 review available for amiodarone and Marfan Syndrome
| Article | Year |
|---|---|
[Idiopathic mitral valve prolapse].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anticoagulants; Arrhythmias, Cardiac; Diagnosis, Differenti | 1983 |
2 other studies available for amiodarone and Marfan Syndrome
| Article | Year |
|---|---|
[Amiodarone-induced hyperthyroidism].
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Humans; Hyperthyroidism; Male; Marfan Syndrome; Tachycard | 2000 |
Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome.
Topics: Adult; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Marfan Syndrome; Thyroid Function T | 1985 |